← Back to Search

EHR + BPA + Support Staff for Alcoholism (RACE Trial)

N/A
Waitlist Available
Led By Emily Hurstak, MD MPH
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Clinician Participants: Adult (18 years or older), Physician or Nurse Practitioner practicing Primary Care at Boston Medical Center in the General Internal Medicine (GIM) Primary Care Clinic, Current position in the practice expected to be unchanged for a minimum of 18 months (not a graduating trainee)
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

RACE Trial Summary

This trial seeks to improve care of people with unhealthy alcohol use using electronic health records (EHRs), Best Practice Advisories (BPA), clinical decision support (CDS) and support staff such as clinical care managers (CCM) and population health managers (PHM).

Who is the study for?
This trial is for adult primary care physicians and nurse practitioners at Boston Medical Center's General Internal Medicine Clinic. They should expect to remain in their current position for at least 18 months and have had a completed patient visit in the last year and a half.Check my eligibility
What is being tested?
The study tests how different support tools within electronic health records can help manage unhealthy alcohol use. It compares four methods: Best Practice Advisory (BPA) alone, BPA with Population Health Management (PHM), BPA with Clinical Care Management (CCM), or all three combined.See study design
What are the potential side effects?
Since this trial involves organizational interventions rather than medications, traditional side effects are not applicable. However, there may be indirect impacts on workflow or time management for clinicians involved.

RACE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a primary care physician or nurse over 18, working at Boston Medical Center's GIM clinic, not planning to leave for at least 18 months.

RACE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol Use Disorder
Secondary outcome measures
Number Completed Encounter for Alcohol Use Disorder (AUD) Specialty Care
Number of Acute Care Utilization
Number of Acute Care Utilization with an Alcohol-related Diagnosis
+5 more

RACE Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: BPA plus Population Health Management plus Clinical Care Management (BPA+PHM+CCM)Experimental Treatment1 Intervention
Access to the existing Epic BPA risky alcohol use and alcohol use disorder + targeted support by a population health manager (PHM) and clinician care manager (CCM)
Group II: BPA plus Population Health Management (BPA+PHM)Experimental Treatment1 Intervention
Access to the existing Epic BPA for risky alcohol use and alcohol use disorder + targeted support by a population health manager (PHM).
Group III: BPA plus Clinical Care Management (BPA+CCM)Experimental Treatment1 Intervention
Access to the existing Epic BPA for risky alcohol use and alcohol use disorder + targeted support by a clinician care manager (CCM).
Group IV: Clinician prompting and Decision Support, Best Practice Advisory (BPA)Active Control1 Intervention
Access to an existing BPA for risky alcohol use and alcohol use disorder.

Find a Location

Who is running the clinical trial?

Boston Medical CenterLead Sponsor
382 Previous Clinical Trials
869,313 Total Patients Enrolled
11 Trials studying Alcoholism
6,131 Patients Enrolled for Alcoholism
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
791 Previous Clinical Trials
1,356,850 Total Patients Enrolled
417 Trials studying Alcoholism
983,271 Patients Enrolled for Alcoholism
Emily Hurstak, MD MPHPrincipal InvestigatorBoston Medical Center, General Internal Medicine

Media Library

BPA plus Population Health Management (BPA+PHM) Clinical Trial Eligibility Overview. Trial Name: NCT05492942 — N/A
Alcoholism Research Study Groups: Clinician prompting and Decision Support, Best Practice Advisory (BPA), BPA plus Population Health Management (BPA+PHM), BPA plus Clinical Care Management (BPA+CCM), BPA plus Population Health Management plus Clinical Care Management (BPA+PHM+CCM)
Alcoholism Clinical Trial 2023: BPA plus Population Health Management (BPA+PHM) Highlights & Side Effects. Trial Name: NCT05492942 — N/A
BPA plus Population Health Management (BPA+PHM) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05492942 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers still recruiting participants for this experiment?

"It appears that the medical study is not presently accepting new participants, based on data recorded on clinicaltrials.gov; this trial was published November 11th 2022 and received its most recent update November 18th 2022. However, there are 365 other trials available for potential volunteers to enrol in currently."

Answered by AI
~37 spots leftby Oct 2024